These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11151862)

  • 21. Are endoscopic antireflux therapies cost-effective compared with laparoscopic fundoplication?
    Schiefke I; Rogalski C; Zabel-Langhennig A; Witzigmann H; Mössner J; Hasenclever D; Caca K
    Endoscopy; 2005 Mar; 37(3):217-22. PubMed ID: 15731937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review article: alternative approaches to the long-term management of GERD.
    Fennerty MB
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():39-44. PubMed ID: 16303036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux disease.
    Funk LM; Zhang JY; Drosdeck JM; Melvin WS; Walker JP; Perry KA
    Surgery; 2015 Jan; 157(1):126-36. PubMed ID: 25262216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist].
    Habu Y; Yoshino T; Shio S; Hayakumo T; Kawai K
    Nihon Rinsho; 2004 Aug; 62(8):1504-9. PubMed ID: 15344541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review: treatment of gastroesophageal reflux disease in the elderly.
    Poh CH; Navarro-Rodriguez T; Fass R
    Am J Med; 2010 Jun; 123(6):496-501. PubMed ID: 20569750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Refractory GERD": acid, nonacid, or not GERD?
    Vaezi MF
    Am J Gastroenterol; 2004 Jun; 99(6):989-90. PubMed ID: 15180714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost effectiveness of rabeprazole versus generic ranitidine for symptom resolution in patients with erosive esophagitis.
    Ofman JJ; Yamashita BD; Siddique RM; Larson LR; Willian MK
    Am J Manag Care; 2000 Aug; 6(8):905-16. PubMed ID: 11186502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic approaches to reflux disease, focusing on acid secretion.
    Kinoshita Y; Adachi K; Fujishiro H
    J Gastroenterol; 2003 Mar; 38 Suppl 15():13-9. PubMed ID: 12698865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical or invasive therapy for GERD: an acidulous analysis.
    Spechler SJ
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):81-8. PubMed ID: 15017499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic reflections on proton pump inhibitor therapy for non-erosive reflux disease.
    Moayyedi P
    Digestion; 2008; 78 Suppl 1():61-9. PubMed ID: 18832842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burden and cost of treatment for GERD.
    Kinoshita Y; Sato S
    J Gastroenterol; 2005 Nov; 40(11):1083-4. PubMed ID: 16322958
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease.
    Tack J
    Curr Opin Gastroenterol; 2005 Jul; 21(4):454-60. PubMed ID: 15930988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-reflux surgery in patients with adequate response to proton pump inhibitors - is there an indication?].
    Horstmann R; Gregor N; Classen C; Röttgermann S; Palmes D
    Z Gastroenterol; 2006 Dec; 44(12):1217-22. PubMed ID: 17163371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in the treatment of GERD in the elderly: focus on proton pump inhibitors.
    Pilotto A; Franceschi M; Paris F
    Int J Clin Pract; 2005 Oct; 59(10):1204-9. PubMed ID: 16178989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastroesophageal reflux disease as a cause of death is increasing: analysis of fatal cases after medical and surgical treatment.
    Rantanen TK; Sihvo EI; Räsänen JV; Salo JA
    Am J Gastroenterol; 2007 Feb; 102(2):246-53. PubMed ID: 17156140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroesophageal reflux disease.
    Rochman MV; Prescott J; Cave DG
    Manag Care Interface; 1999 Apr; 12(4):65-7. PubMed ID: 10387394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current medical treatment and indications for surgical referral for gastroesophageal reflux disease (GERD).
    Katz PO; Castell DO
    Semin Thorac Cardiovasc Surg; 1997 Apr; 9(2):169-72. PubMed ID: 9253080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: acid suppression in the management of gastro-oesophageal reflux disease--an appraisal of treatment options in primary care.
    Jones R; Bytzer P
    Aliment Pharmacol Ther; 2001 Jun; 15(6):765-72. PubMed ID: 11380314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of pathophysiology, severity, and cost on the medical management of gastroesophageal reflux disease.
    Reynolds JC
    Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S5-12. PubMed ID: 8931825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of gastroesophageal reflux disease in a managed care environment. Based on a presentation by Kevin Ashby, MD.
    Am J Manag Care; 2000 May; 6(9 Suppl):S480-3. PubMed ID: 10977488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.